Candel Therapeutics, Inc. (CADL)
10.18
+0.02
(+0.20%)
USD |
NASDAQ |
Oct 02, 16:00
10.20
+0.02
(+0.15%)
After-Hours: 20:00
Candel Therapeutics Market Cap : 774.88M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 774.88M |
| October 01, 2026 | 773.36M |
| September 30, 2026 | 794.68M |
| September 29, 2026 | 828.17M |
| September 28, 2026 | 851.76M |
| September 25, 2026 | 838.82M |
| September 24, 2026 | 879.17M |
| September 23, 2026 | 859.38M |
| September 22, 2026 | 902.00M |
| September 21, 2026 | 853.29M |
| September 18, 2026 | 825.88M |
| September 17, 2026 | 863.18M |
| September 16, 2026 | 838.82M |
| September 15, 2026 | 846.44M |
| September 14, 2026 | 812.56M |
| September 11, 2026 | 802.67M |
| September 10, 2026 | 862.42M |
| September 09, 2026 | 926.36M |
| September 08, 2026 | 959.09M |
| September 04, 2026 | 972.79M |
| September 03, 2026 | 987.25M |
| September 02, 2026 | 1.005B |
| September 01, 2026 | 978.12M |
| August 31, 2026 | 994.87M |
| August 28, 2026 | 994.87M |
| Date | Value |
|---|---|
| August 27, 2026 | 1.047B |
| August 26, 2026 | 1.011B |
| August 25, 2026 | 1.035B |
| August 24, 2026 | 978.88M |
| August 21, 2026 | 999.43M |
| August 20, 2026 | 940.06M |
| August 19, 2026 | 1.028B |
| August 18, 2026 | 917.23M |
| August 17, 2026 | 925.60M |
| August 14, 2026 | 892.11M |
| August 13, 2026 | 898.20M |
| August 12, 2026 | 812.94M |
| August 11, 2026 | 810.66M |
| August 10, 2026 | 799.24M |
| August 07, 2026 | 775.80M |
| August 06, 2026 | 775.07M |
| August 05, 2026 | 766.28M |
| August 04, 2026 | 769.94M |
| August 03, 2026 | 737.71M |
| July 31, 2026 | 733.31M |
| July 30, 2026 | 723.06M |
| July 29, 2026 | 688.62M |
| July 28, 2026 | 709.14M |
| July 27, 2026 | 729.65M |
| July 24, 2026 | 700.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 370.35M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
Market Cap Related Metrics
| PEG Ratio | -0.0686 |
| Price to Book Value | 6.144 |
| Price | 10.18 |
| Earnings Yield | -13.85% |
| PEGY Ratio | -0.0686 |